Company: QXO-PB
Filing Date: 2025-05-29
Form Type: 424B7
Source: 0001104659-25-054254
Chunk: 16

Company: QXO, Inc.
Filing Date: 2025-05-29
Form: 424B7
Chunk 16
---
 and to pay related fees and expenses; (iii) the consummation of the Company’s private placement of approximately 67.5 million shares of our common stock, at a purchase price of $12.30 per share, and the application of the net proceeds to pay a portion of the consideration for the Beacon Acquisition and to pay fees and expenses related to the Transactions; (iv) the consummation of the Beacon Acquisition and (v) the consummation of the May 2025 Equity Offerings and the application of the net proceeds to repay indebtedness outstanding under the Term Loan Facility.

#### Corporate Information
Our principal executive offices are located at Five American Lane, Greenwich, Connecticut 06831. Our telephone number is (888) 998-6000. Our website is www.qxo.com. The information on our website is not incorporated by reference into this prospectus supplement or the accompanying prospectus (except for SEC reports that are expressly incorporated by reference herein).

<div align='center'>S-6</div>

TABLE OF CONTENTS

#### The Offering
Issuer

QXO, Inc.

Shares of common stock offered by the selling stockholders

67,528,459 shares of common stock.

Use of proceeds

We will not receive any proceeds from the sale of shares by the selling stockholders.

Trading Market

Our common stock is listed on the NYSE under the symbol “QXO.”

Risk factors

Investing in our shares involves significant risks. See “Risk Factors” in this prospectus supplement, as well as other information included in or incorporated by reference into this prospectus supplement and the accompanying prospectus for a discussion of the factors you should carefully consider before deciding to invest in our shares.

Unless otherwise indicated, all applicable share, per share and related information in this prospectus supplement is based on 578,265,506 shares of common stock outstanding as of May 23, 2025, and excludes, in each case as of such date:

•

29,797,826 shares of common stock issuable upon vesting of restricted stock units (“RSUs”) or performance-based restricted stock units (“PSUs”) outstanding as of May 15, 2025;

•

3,954,152 shares of common stock issuable upon the exercise of options granted under the QXO, Inc. 2024 Omnibus Incentive Compensation Plan (the “Plan”) as of May 15, 2025, at a weighted- average exercise price of $ 5.04 per share